Nevakar Injectables Inc.
Patent owner in reexamination·4 ex parte reexams
Nevakar Injectables Inc.'s patents have been the subject of 4 USPTO ex parte reexaminations, with 2 currently open. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
225
226
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (4)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/016,021 | Mar 2, 2026 | 11,207,280 | EPINEPHRINE COMPOSITIONS AND CONTAINERS | — | Closed |
| 90/015,927 | Jan 30, 2026 | 12,533,328 | EPINEPHRINE COMPOSITIONS AND CONTAINERS | — | Open |
| 90/015,851 | Dec 31, 2025 | 12,508,238 | EPINEPHRINE COMPOSITIONS AND CONTAINERS | — | Open |
| 90/019,939 | Apr 30, 2025 | 11,207,280 | EPINEPHRINE COMPOSITIONS AND CONTAINERS | — | Closed |
See the full reexam picture for Nevakar Injectables Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.